Definium Therapeutics, Inc. Common Shares (DFTX) is a publicly traded the market company. As of October 23, 2026, DFTX trades at $35.85 with a market cap of $4.77B and a P/E ratio of 0.00. DFTX moved -0.41% today. Year to date, DFTX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $14.62 to $49.70. Analyst consensus is strong buy with an average price target of $72.75. Rallies surfaces DFTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for DFTX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $35.85 |
| Market Cap | $4.77B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $49.70 |
| 52-Week Low | $14.62 |
| Volume | 909 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
16 analysts cover DFTX: 0 strong buy, 16 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $72.75.